Development of liposomes using formulation by design: Basics to recent advances

Area of Science:

• Pharmaceutical Sciences
• Drug Delivery Systems
• Formulation Development

Background:

• Traditional "One Factor at a Time" (OFAT) methods have limitations in optimizing complex systems.
• Design of Experiments (DoE) offers a systematic approach to optimization.
• Quality by Design (QbD) principles, specifically Formulation by Design (FbD), are increasingly adopted for enhanced product and process understanding.

Purpose of the Study:

• To review the fundamentals and methodologies of Formulation by Design (FbD).
• To highlight the application of FbD in the development of liposomes as vesicular drug carriers.
• To emphasize the importance of robustness and reproducibility in liposome formulation for industrial scale-up.

Main Methods:

• Exploration of various DoE methodologies including Central Composite, Simplex Mixture, Box-Behnken, Factorial, Taguchi, Simplex Centroid, d-optimal, Placket Burman, and Orthogonal arrays.
• Focus on QbD-based approaches for formulation development.
• Review of literature on FbD applications in liposome research.

Main Results:

• FbD provides a deeper understanding of product and process parameters.
• Systematic optimization using FbD enhances the robustness and reproducibility of liposome formulations.
• Various DoE techniques can be effectively applied to liposome development.

Conclusions:

• FbD is a powerful strategy for optimizing liposome drug delivery systems.
• Adoption of FbD facilitates the development of high-quality, reproducible liposomes suitable for industrialization.
• This review provides a comprehensive overview of FbD methodologies for liposome formulation.